Who owns THERIVA BIOLOGICS INC?
- Ticker: TOVX
- CUSIP Number: 87164u508
Tip: Access positions for across all investors
Analyze quarterly positions in Theriva Biologics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Theriva Biologics stock
Who bought or sold THERIVA BIOLOGICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 450k | $88k | 112% | Mar 2026 |
|
| Vanguard Group | 256k | $54k | 1461% | Dec 2025 |
|
| Virtu Financial | 253k | $50k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 242k | $47k | 100% | Mar 2026 |
|
| UBS Group | 226k | $44k | 18% | Mar 2026 |
|
| Vanguard Capital Management | 192k | $38k | 100% | Mar 2026 |
|
| Jane Street | 177k | $35k | 100% | Mar 2026 |
|
| Ikarian Capital | 112k | $22k | 0% | Mar 2026 |
|
| Two Sigma Securities | 105k | $21k | 145% | Mar 2026 |
|
| XTX Topco | 39k | $8.3k | 20% | Dec 2025 |
|
| Boothbay Fund Management | 28k | $5.4k | 0% | Mar 2026 |
|
| Morgan Stanley | 24k | $4.6k | -88% | Mar 2026 |
|
| Intl Fcstone | 22k | $4.4k | -40% | Mar 2026 |
|
| Two Sigma Investments | 15k | $3.0k | -64% | Mar 2026 |
|
| Schwarz Dygos Wheeler Investment Advisors | 15k | $2.9k | 0% | Mar 2026 |
|
| BlackRock | 7.5k | $1.5k | 0% | Mar 2026 |
|
| Citigroup | 1.4k | $271.940500 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 448.00 | $149.318400 | 1% | Dec 2025 |
|
| SBI Securities | 131.00 | $26.003500 | 122% | Mar 2026 |
|
| IFP Advisors | 11.00 | $1.999800 | 0% | Mar 2026 |
|
| Newbridge Financial Services Group | 5.00 | $1.000000 | 0% | Mar 2026 |
|
| Royal Bank of Canada | 1.00 | $0 | 100% | Mar 2026 |
|
| Danske Bank A/s | 1.00 | $0 | 0% | Mar 2026 |
|
Who sold out of Theriva Biologics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 42k | $8.8k |
| Barclays | Dec 2025 | 33k | $6.9k |